Dingdang Health Technology Group Ltd. (9886.HK)
HKD 0.35
(-1.43%)
HKD 0.35
(-1.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -73.35 Million CNY | 31.8% |
| 2022 | -223.78 Million CNY | 64.65% |
| 2021 | -632.98 Million CNY | -533.89% |
| 2020 | -99.85 Million CNY | 8.9% |
| 2019 | -109.61 Million HKD | -187.38% |
| 2018 | -38.14 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -45.21 Million HKD | 0.15% |
| 2024 Q1 | -45.59 Million HKD | 22.95% |
| 2023 Q2 | -67.29 Million HKD | 5.52% |
| 2023 Q1 | -71.22 Million HKD | -39.21% |
| 2023 FY | - CNY | 31.8% |
| 2023 Q4 | -60.36 Million HKD | -2.57% |
| 2023 Q3 | -58.84 Million HKD | 12.55% |
| 2022 Q3 | -49.87 Million HKD | 43.97% |
| 2022 Q1 | -95.46 Million HKD | 0.0% |
| 2022 FY | - CNY | 64.65% |
| 2022 Q2 | -89 Million HKD | 6.76% |
| 2022 Q4 | -51.16 Million HKD | -2.58% |
| 2021 Q1 | -56.2 Million HKD | 0.0% |
| 2021 FY | - CNY | -533.89% |
| 2020 FY | - CNY | 8.9% |
| 2020 Q1 | 18.83 Million HKD | 0.0% |
| 2019 FY | - HKD | -187.38% |
| 2018 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|